BioScience Health Innovations, Inc.
BHIC
$4.00
-$32.04-88.90%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -35.62% | 43.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -35.62% | 43.22% | |||
| Cost of Revenue | -36.57% | 106.41% | |||
| Gross Profit | -35.02% | 19.91% | |||
| SG&A Expenses | 14.62% | 31.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.28% | 62.41% | |||
| Operating Income | -101.92% | 7.24% | |||
| Income Before Tax | -101.92% | 7.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -101.92% | 7.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -101.92% | 7.24% | |||
| EBIT | -101.92% | 7.24% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -101.92% | 7.20% | |||
| Normalized Basic EPS | -101.92% | 7.41% | |||
| EPS Diluted | -102.00% | 2.83% | |||
| Normalized Diluted EPS | -101.94% | 7.05% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.95% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||